Mai, N., Liu, B., Safonov, A., Shen, S., Zelizer, S., White, C., Chen, Y., Razavi, P., Jhaveri, K. L., Modi, S., Chandarlapaty, S., Drago, J. Z. (2025). Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1045